BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8806527)

  • 21. Incorporation of deoxyribonucleotides and ribonucleotides by a dNTP-binding cleft mutated reverse transcriptase in hepatitis B virus core particles.
    Kim HY; Kim HY; Jung J; Park S; Shin HJ; Kim K
    Virology; 2008 Jan; 370(1):205-12. PubMed ID: 17900649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta.
    Cho G; Suh SW; Jung G
    Biochem Biophys Res Commun; 2000 Jul; 274(1):203-11. PubMed ID: 10903919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.
    Unchwaniwala N; Sherer NM; Loeb DD
    J Virol; 2016 Oct; 90(19):8705-19. PubMed ID: 27440888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in conserved domain II of the large (L) subunit of the Sendai virus RNA polymerase abolish RNA synthesis.
    Smallwood S; Easson CD; Feller JA; Horikami SM; Moyer SA
    Virology; 1999 Sep; 262(2):375-83. PubMed ID: 10502516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus polymerase suppresses translation of pregenomic RNA via a mechanism involving its interaction with 5' stem-loop structure.
    Ryu DK; Kim S; Ryu WS
    Virology; 2008 Mar; 373(1):112-23. PubMed ID: 18155120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.
    Köck J; Nassal M; Deres K; Blum HE; von Weizsäcker F
    J Virol; 2004 Dec; 78(24):13812-8. PubMed ID: 15564489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in domain V of the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo.
    Cortese CK; Feller JA; Moyer SA
    Virology; 2000 Nov; 277(2):387-96. PubMed ID: 11080486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.
    Hu J; Boyer M
    J Virol; 2006 Mar; 80(5):2141-50. PubMed ID: 16474122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting.
    Chang LJ; Pryciak P; Ganem D; Varmus HE
    Nature; 1989 Jan; 337(6205):364-8. PubMed ID: 2463489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.
    Lanford RE; Kim YH; Lee H; Notvall L; Beames B
    J Virol; 1999 Mar; 73(3):1885-93. PubMed ID: 9971767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.
    Ladner SK; Miller TJ; Otto MJ; King RW
    Antivir Chem Chemother; 1998 Jan; 9(1):65-72. PubMed ID: 9875378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication.
    Lan YT; Li J; Liao W; Ou J
    Virology; 1999 Jul; 259(2):342-8. PubMed ID: 10388659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus mutations associated with antiviral therapy.
    Bartholomeusz A; Locarnini S
    J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.
    Lam W; Li Y; Liou JY; Dutschman GE; Cheng YC
    Mol Pharmacol; 2004 Feb; 65(2):400-6. PubMed ID: 14742682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.
    Leupin O; Bontron S; Schaeffer C; Strubin M
    J Virol; 2005 Apr; 79(7):4238-45. PubMed ID: 15767425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrophobic residues of terminal protein domain of hepatitis B virus polymerase contribute to distinct steps in viral genome replication.
    Shin YC; Ko C; Ryu WS
    FEBS Lett; 2011 Dec; 585(24):3964-8. PubMed ID: 22079666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of an enzymatically active polymerase of human hepatitis B virus in an coupled transcription-translation system.
    Li Z; Tyrrell DL
    Biochem Cell Biol; 1999; 77(2):119-26. PubMed ID: 10438146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.
    Boregowda RK; Adams C; Hu J
    J Virol; 2012 Jun; 86(12):6522-36. PubMed ID: 22514346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro phenotyping of recombinant hepatitis B virus containing the polymerase/reverse transcriptase gene from clinical isolates.
    Liu Y; Kitrinos KM
    Methods Mol Biol; 2013; 1030():163-81. PubMed ID: 23821268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds.
    Lin L; Hu J
    J Virol; 2008 Mar; 82(5):2305-12. PubMed ID: 18094191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.